{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:25:05Z","timestamp":1771691105136,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The apparent lack of additional missense mutations data on mixed-phenotype leukemia is noteworthy. Single amino acid substitution by these non-synonymous single nucleotide variations can be related to many pathological conditions and may influence susceptibility to disease. This case-control study aimed to unravel whether the <jats:italic>ZAP70<\/jats:italic> missense variant (rs104893674 (C\u2009&gt;\u2009A)) underpinning mixed-phenotype leukemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The rs104893674 was genotyped in clients who were mixed-phenotype acute leukemia-, acute lymphoblastic leukemia- and acute myeloid leukemia-positive and matched healthy controls, which have been referred to all major urban hospitals from multiple provinces of country- wide, IRAN, from February 11\u2019 2019 to June 10\u2019 2023, by amplification refractory mutation system-polymerase chain reaction method. Direct sequencing for rs104893674 of the <jats:italic>ZAP70<\/jats:italic> gene was performed in a 3130 Genetic Analyzer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that the AC genotype of individuals with A allele at this polymorphic site (heterozygous variant-type) contribute to the genetic susceptibility to acute leukemia of both forms, acute myeloid leukemia and acute lymphoblastic leukemia as well as with a mixed phenotype. In other words, the <jats:italic>ZAP70<\/jats:italic> missense variant (rs104893674 (C\u2009&gt;\u2009A)) increases susceptibility of distinct cell populations of different (myeloid and lymphoid) lineages to exhibiting cancer phenotype. The results were all consistent with genotype data obtained using a direct DNA sequencing technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Of special interest are pathogenic missense mutations, since they generate variants that cause specific molecular phenotypes through protein destabilization. Overall, we discovered that the rs104893674 (C\u2009&gt;\u2009A) variant chance in causing mixed-phenotype leukemia is relatively high.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01961-0","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:03:01Z","timestamp":1723039381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic evidence for predisposition to acute leukemias due to a missense mutation (p.Ser518Arg) in ZAP70 kinase: a case-control study"],"prefix":"10.1186","volume":"17","author":[{"given":"Khalil","family":"Khashei Varnamkhasti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samire","family":"Khashei Varnamkhasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Shahrouzian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoomeh","family":"Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Naeimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrouz","family":"Naeimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirous","family":"Naeimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"1","key":"1961_CR1","first-page":"24","volume":"2","author":"JN Bhalodia","year":"2011","unstructured":"Bhalodia JN, Patel MM. Profile of Pediatric Malignancy: A three-year study. Nat J Community Med. 2011;2(1):24\u20137.","journal-title":"Nat J Community Med"},{"issue":"3","key":"1961_CR2","first-page":"276","volume":"6","author":"B George","year":"2022","unstructured":"George B, Gonzalez A, Rios A. Inside the Biology of Acute Leukemias of Ambiguous Lineage: Diagnostic Work-Up, genomic and clinical characterization. J Cancer Sci Clin. 2022;6(3):276\u201380.","journal-title":"J Cancer Sci Clin"},{"issue":"8","key":"1961_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.exphem.2016.05.003","volume":"44","author":"OS Eckstein","year":"2016","unstructured":"Eckstein OS, Wang L, Punia JN, Kornblau SM, Andreeff M, Wheeler DA. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol. 2016;44(8):740\u20134.","journal-title":"Exp Hematol"},{"key":"1961_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00277-018-3297-6","volume":"97","author":"M Khan","year":"2018","unstructured":"Khan M, Siddiqi R, Naqvi K. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Ann Hematol. 2018;97:945\u201353.","journal-title":"Ann Hematol"},{"issue":"2","key":"1961_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11912-020-01010-w","volume":"23","author":"TB Alexander","year":"2021","unstructured":"Alexander TB, Orgel E. Mixed phenotype Acute Leukemia: current approaches to diagnosis and treatment. Curr Oncol Rep. 2021;23(2):22.","journal-title":"Curr Oncol Rep"},{"issue":"29","key":"1961_CR6","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.2174\/1381612823666170616082125","volume":"23","author":"M Kim","year":"2017","unstructured":"Kim M, Baek M, Kim DJ. Protein Tyrosine Signaling and its potential therapeutic implications in Carcinogenesis. Curr Pharm Des. 2017;23(29):4226\u201346.","journal-title":"Curr Pharm Des"},{"issue":"7605","key":"1961_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature17960","volume":"534","author":"Y Jia","year":"2016","unstructured":"Jia Y, Yun CH, Park E, Ercan D, Manuia M, Juarez J, et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Nature. 2016;534(7605):129\u201332.","journal-title":"Nature"},{"key":"1961_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fpls.2014.00190","volume":"5","author":"P Crozet","year":"2014","unstructured":"Crozet P, Margalha L, Confraria A, Rodrigues A, Martinho C, Adamo M, et al. Mechanisms of regulation of SNF1\/AMPK\/SnRK1 protein kinases. Front Plant Sci. 2014;5:190.","journal-title":"Front Plant Sci"},{"issue":"11","key":"1961_CR9","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.3390\/ijms22115416","volume":"22","author":"M Petrosino","year":"2021","unstructured":"Petrosino M, Novak L, Pasquo A, Chiaraluce R, Turina P, Capriotti E, et al. Analysis and interpretation of the impact of missense variants in Cancer. Int J Mol Sci. 2021;22(11):5416.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1961_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbrc.2015.11.093","volume":"469","author":"D Fu","year":"2016","unstructured":"Fu D, Liu B, Zang LE, Jiang H. MiR-631\/ZAP70: a novel axis in the migration and invasion of prostate cancer cells. Biochem Biophys Res Commun. 2016;469(3):345\u201351.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1961_CR11","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/stem.470","volume":"28","author":"Y Cha","year":"2010","unstructured":"Cha Y, Moon BH, Lee MO, Ahn HJ, Lee HJ, Lee KA, et al. Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1\/Stat3\/c-Myc signaling. Stem Cells. 2010;28(9):1476\u201386.","journal-title":"Stem Cells"},{"issue":"5","key":"1961_CR12","first-page":"1297","volume":"25","author":"MY Huang","year":"2011","unstructured":"Huang MY, Wang JY, Chang HJ, Kuo CW, Tok TS, Lin SR. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer. Oncol Rep. 2011;25(5):1297\u2013306.","journal-title":"Oncol Rep"},{"key":"1961_CR13","doi-asserted-by":"publisher","first-page":"826784","DOI":"10.4061\/2011\/826784","volume":"2011","author":"D Park","year":"2011","unstructured":"Park D, Jeong HO, Kim BC, Ha YM, Young Chung H. Computational approach to identify enzymes that are potential therapeutic candidates for psoriasis. Enzyme Res. 2011;2011:826784.","journal-title":"Enzyme Res"},{"issue":"10","key":"1961_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.prp.2015.07.007","volume":"211","author":"J Chen","year":"2015","unstructured":"Chen J, Huang C, Zhu Y, Dong L, Cao W, Sun L, et al. Identification of similarities and differences between myeloid and lymphoid acute leukemias using a gene-gene interaction network. Pathol Res Pract. 2015;211(10):789\u201396.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1961_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/cgp.20424","volume":"21","author":"I Panagopoulos","year":"2024","unstructured":"Panagopoulos I, Andersen K, Johannsdottir IMR, Tands\u00e6ther MR, Micci F, Heim S. Genetic characterization of Pediatric mixed phenotype Acute Leukemia (MPAL). Cancer Genomics Proteom. 2024;21(1):1\u201311.","journal-title":"Cancer Genomics Proteom"},{"issue":"1","key":"1961_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1186\/s12884-023-06143-x","volume":"23","author":"S Parhoudeh","year":"2023","unstructured":"Parhoudeh S, Saadaty A, Khashei Varnamkhasti K, Khashei Varnamkhasti S, Naeimi L, Naeimi S. Highlighting allelic variations at the interleukin-19 locus in term of preeclampsia predisposing factors and access to an accurate diagnostic\/screening option. BMC Pregnancy Childbirth. 2023;23(1):839.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"1961_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jcla.21540","volume":"26","author":"GV Alves","year":"2012","unstructured":"Alves GV, Fernandes AL, Freire JM, Paiva Ade S, Vasconcelos RC, Sales VS, et al. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome. J Clin Lab Anal. 2012;26(6):431\u201340.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1961_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13104-023-06635-1","volume":"16","author":"A Ameri","year":"2023","unstructured":"Ameri A, Khashei Varnamkhasti K, Parhoudeh S, Khashei Varnamkhasti S, Naeimi L, Naeimi S. Spontaneous miscarriage driven by maternal genetic mutation at position of PAI-1-844G\/A: shed light on a race-specific genetic polymorphism. BMC Res Notes. 2023;16(1):360.","journal-title":"BMC Res Notes"},{"issue":"8","key":"1961_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11912-022-01252-w","volume":"24","author":"MC B\u00e9n\u00e9","year":"2022","unstructured":"B\u00e9n\u00e9 MC, Porwit A. Mixed Phenotype\/Lineage leukemia: has anything changed for 2021 on diagnosis, classification, and treatment? Curr Oncol Rep. 2022;24(8):1015\u201322.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"1961_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/cddis.2013.107","volume":"4","author":"JT Lynch","year":"2013","unstructured":"Lynch JT, Somerville TD, Spencer GJ, Huang X, Somervaille TC. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells. Cell Death Dis. 2013;4(4):573.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1961_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3835(03)00442-7","volume":"213","author":"K Shigeno","year":"2004","unstructured":"Shigeno K, Yoshida H, Pan L, Luo JM, Fujisawa S, Naito K, et al. Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. Cancer Lett. 2004;213(1):11\u201320.","journal-title":"Cancer Lett"},{"issue":"11","key":"1961_CR22","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.leukres.2013.08.004","volume":"37","author":"U Schnetzke","year":"2013","unstructured":"Schnetzke U, Fischer M, Spies-Weisshart B, Zirm E, Hochhaus A, M\u00fcller JP, et al. The E3 ubiquitin ligase TRAF2 can contribute to TNF-\u03b1 resistance in FLT3-ITD-positive AML cells. Leuk Res. 2013;37(11):1557\u201364.","journal-title":"Leuk Res"},{"key":"1961_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","volume":"16","author":"WJ Leonard","year":"1998","unstructured":"Leonard WJ, O\u2019Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293\u2013322.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1961_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1034\/j.1600-0609.2003.00140.x","volume":"71","author":"M Graf","year":"2003","unstructured":"Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Nuessler V, et al. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. Eur J Haematol. 2003;71(5):366\u201376.","journal-title":"Eur J Haematol"},{"issue":"9","key":"1961_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2105-11-S9-S5","volume":"11","author":"J Zhang","year":"2010","unstructured":"Zhang J, Xiang Y, Ding L, Keen-Circle K, Borlawsky TB, Ozer HG, et al. Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia. BMC Bioinformatics. 2010;11(9):5.","journal-title":"BMC Bioinformatics"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01961-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:04:48Z","timestamp":1723039488000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01961-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1961"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01961-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Islamic Azad University- Kazerun Branch Ethics Committee (IR.IAU.KAU.REC.1398.051). All methods were performed in accordance with the guidelines and regulations of the Islamic Azad University- Kazerun Branch. Written informed consent was provided by all the participants before entering the study groups.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}